Abec-L - Abacavir 600 mg & Lamivudine 300 mg Tablets

Abacavir 600 mg and Lamivudine 300 mg is a combination antiretroviral medicine used as part of HIV treatment regimens. Abacavir and lamivudine belong to the nucleoside reverse transcriptase inhibitor (NRTI) class and work together to interfere with HIV replication. This combination provides a convenient dual-ingredient approach to antiretroviral therapy, supporting viral suppression and helping maintain immune-system function. The tablet formulation simplifies oral treatment by bringing both active ingredients into a single dosage form. It is incorporated into individualized HIV treatment plans under the guidance of qualified healthcare professionals.